Skip to content
healthcare.dev

Carisoprodol

NDC 51525-5901, carisoprodol, tablet, from Mylan Pharmaceuticals Inc..

Product NDC
51525-5901
Status
Listed
Labeler
Mylan Pharmaceuticals Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA011792
DEA schedule
CIV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51525-5901 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARISOPRODOL250 mg/1

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
51525-5901-151525590101100 TABLET in 1 BOTTLE (51525-5901-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7c9184c0-7a2e-11df-8c8d-0002a5d5c51b
  • NADAC price for package 51525590101

    GET /v1/drugs/nadac/51525590101

Use it

Look up 51525-5901 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51525-5901 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51525-5901. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.